X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (898) 898
index medicus (881) 881
male (862) 862
adult (524) 524
testicular neoplasms - drug therapy (512) 512
seminoma - drug therapy (454) 454
oncology (430) 430
testicular neoplasms - pathology (407) 407
seminoma (355) 355
chemotherapy (351) 351
middle aged (341) 341
cancer (282) 282
antineoplastic combined chemotherapy protocols - therapeutic use (279) 279
seminoma - pathology (270) 270
testicular cancer (261) 261
testicular neoplasms - surgery (207) 207
neoplasm staging (205) 205
treatment outcome (195) 195
germ-cell tumors (189) 189
prognosis (182) 182
urology & nephrology (181) 181
adolescent (175) 175
combined modality therapy (173) 173
orchiectomy (166) 166
seminoma - surgery (163) 163
cisplatin - administration & dosage (161) 161
radiotherapy (159) 159
antineoplastic agents - therapeutic use (153) 153
tumors (152) 152
testicular neoplasms - therapy (151) 151
testicular neoplasms - radiotherapy (140) 140
cisplatin (138) 138
etoposide - administration & dosage (134) 134
testis (129) 129
aged (125) 125
follow-up studies (123) 123
neoplasms, germ cell and embryonal - drug therapy (122) 122
seminoma - radiotherapy (121) 121
retrospective studies (120) 120
risk factors (113) 113
seminoma - therapy (113) 113
bleomycin - administration & dosage (110) 110
neoplasms, germ cell and embryonal - pathology (100) 100
etoposide (96) 96
seminoma - secondary (96) 96
carboplatin (95) 95
chemotherapy, adjuvant (95) 95
management (93) 93
surveillance (87) 87
testicular neoplasms - diagnosis (84) 84
care and treatment (81) 81
randomized-trial (81) 81
testicular neoplasms - mortality (80) 80
young adult (80) 80
germinoma - drug therapy (79) 79
combination chemotherapy (78) 78
diagnosis (78) 78
germ cell tumors (78) 78
lymphatic metastasis (78) 78
antineoplastic combined chemotherapy protocols - adverse effects (77) 77
carboplatin - therapeutic use (77) 77
disease-free survival (75) 75
seminoma - diagnosis (73) 73
surgery (72) 72
testicular seminoma (72) 72
bleomycin (71) 71
female (71) 71
carboplatin - administration & dosage (70) 70
survival rate (68) 68
cisplatin - therapeutic use (67) 67
abridged index medicus (66) 66
antineoplastic combined chemotherapy protocols - administration & dosage (64) 64
lymph-node dissection (64) 64
risk (64) 64
time factors (63) 63
salvage therapy (62) 62
tomography, x-ray computed (61) 61
therapy (60) 60
seminoma - mortality (59) 59
medicine & public health (58) 58
high-dose chemotherapy (57) 57
testicular neoplasms - genetics (57) 57
experience (55) 55
metastasis (55) 55
lymph node excision (54) 54
health aspects (52) 52
radiotherapy, adjuvant (52) 52
research (51) 51
testis cancer (51) 51
urology (51) 51
germ cell tumor (49) 49
mediastinal neoplasms - drug therapy (49) 49
prognostic factors (49) 49
cisplatin - adverse effects (48) 48
seminoma - complications (48) 48
testicular neoplasms - complications (48) 48
testicular neoplasms - metabolism (48) 48
germinoma - pathology (47) 47
long-term survivors (47) 47
neoplasm metastasis (47) 47
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (869) 869
French (37) 37
German (28) 28
Japanese (27) 27
Spanish (9) 9
Chinese (5) 5
Russian (4) 4
Hungarian (2) 2
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 1 - 7
Abstract Introduction Treatment options for patients with platinum refractory metastatic germ cell tumours (GCT) relapsing after high-dose chemotherapy and... 
Hematology, Oncology and Palliative Medicine | Germ cell cancer | Immunotherapy | PD-L1 | Checkpoint inhibition | Platinum refractory disease | Testicular cancer | PD-1 | LONG-TERM SURVIVAL | PD-L1 EXPRESSION | TUMORS | ONCOLOGY | NIVOLUMAB | CARCINOMA | Lung Neoplasms - drug therapy | Seminoma - diagnostic imaging | Teratoma | Endodermal Sinus Tumor - drug therapy | Compassionate Use Trials | Choriocarcinoma, Non-gestational - secondary | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Tomography, X-Ray Computed | Transplantation, Autologous | Testicular Neoplasms - pathology | Seminoma - metabolism | Stem Cell Transplantation | Mediastinal Neoplasms - drug therapy | Lung Neoplasms - secondary | Adult | Neoplasms, Germ Cell and Embryonal - drug therapy | Retrospective Studies | Choriocarcinoma, Non-gestational - metabolism | Endodermal Sinus Tumor - secondary | Endodermal Sinus Tumor - diagnostic imaging | Ifosfamide - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Seminoma - drug therapy | Testicular Neoplasms - metabolism | Programmed Cell Death 1 Receptor - metabolism | Etoposide - therapeutic use | Neoplasms, Germ Cell and Embryonal - metabolism | Treatment Outcome | Choriocarcinoma, Non-gestational - diagnostic imaging | Endodermal Sinus Tumor - metabolism | Neoplasms, Germ Cell and Embryonal - diagnostic imaging | Cisplatin - therapeutic use | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Lung Neoplasms - diagnostic imaging | Mediastinal Neoplasms - metabolism | Platinum Compounds - administration & dosage | Seminoma - secondary | Choriocarcinoma, Non-gestational - drug therapy | Neoplasms, Germ Cell and Embryonal - secondary | Viral antibodies | Medical research | Relapse | Chemotherapy | Stem cells | Medicine, Experimental | Antibodies | Transplantation | Metastasis | Diseases | Cancer | Apoptosis | Autografts | Cell survival | PD-1 protein | Toxicity | Mortality | Clinical trials | Stem cell transplantation | Patients | Metastases | Inhibitors | Immune checkpoint | Platinum | Cell death | PD-L1 protein | Tumors | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2006, Volume 24, Issue 3, pp. 467 - 475
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2014, Volume 25, Issue 11, pp. 2173 - 2178
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 07/2017, Volume 21, Issue 7, pp. 1300 - 1314
Type II testicular germ cell cancers (TGCT) are the most frequently diagnosed tumours in young men (20–40 years) and are classified as seminoma or... 
differentiation | xenografts | romidepsin | cisplatin resistance | HDAC inhibitor | germ cell cancer | bromodomain proteins | JQ1 | pluripotency | epigenetic therapy | HDAC INHIBITORS | MEDICINE, RESEARCH & EXPERIMENTAL | LINE TCAM-2 | UNDIFFERENTIATED SPERMATOGONIA | CANCER | FAMILY | CELL BIOLOGY | BET | SMALL-MOLECULE INHIBITION | BRD4 | Triazoles - administration & dosage | Testicular Neoplasms - genetics | Apoptosis - drug effects | Humans | Male | Neoplasms, Germ Cell and Embryonal - genetics | Testicular Neoplasms - pathology | Xenograft Model Antitumor Assays | Animals | Testicular Neoplasms - drug therapy | Cell Cycle Checkpoints - drug effects | Cell Differentiation - drug effects | Cell Line, Tumor | Adult | Neoplasms, Germ Cell and Embryonal - drug therapy | Cell Proliferation - drug effects | Mice | Gene Expression Regulation, Neoplastic - drug effects | Azepines - administration & dosage | Neoplasms, Germ Cell and Embryonal - pathology | Proteins | Epigenetic inheritance | Chemotherapy | DNA microarrays | Analysis | Metastasis | Radiotherapy | Apoptosis | Cancer | Therapy | Biotechnology | Histone deacetylase | Transcription | Gene regulation | DNA damage | Displays | Testicular cancer | Metastases | Angiogenesis | Cell cycle | Remission | Damage | Deoxyribonucleic acid--DNA | Radiation therapy | Tumor cell lines | Gene expression | Seminoma | Inhibitors | Men | Testes | Differentiation | In vitro methods and tests | Pluripotency | Tumors | Index Medicus | Original
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 02/2011, Volume 103, Issue 3, pp. 241 - 249
Journal Article
Journal Article
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 08/2013, Volume 119, Issue 15, pp. 2771 - 2777
Journal Article
Annals of Oncology, ISSN 0923-7534, 07/2016, Volume 27, Issue 7, pp. 1299 - 1304
Journal Article